​🧑‍💻Iterative is looking to invest in and support early-stage healthcare startups, from healthtech to biotech.🧑‍🔬

​We believe Southeast Asia (SEA) is in need of a healthcare revolution. With an aging population, strained doctor-to-patient ratios, and vast gaps in access to quality care, there are abundant opportunities for bold healthcare innovators to drive meaningful change in the region. In the last 4 years, we have invested in 15 healthcare startups and are actively seeking founders with a transformative vision for SEA.

​Join us for a live Ask Me Anything (AMA) session where you’ll hear directly from Iterative's Visiting Partner and healthcare portfolio company founders in both healthtech services as well as biotech, as they share insights into healthcare entrepreneurship in SEA and their journeys to building impactful companies.

​Meet the Founders

• ​Jessica Chao, Visiting Partner, Iterative | Healthcare Investor

  • ​Jessica leads Iterative’s healthcare investments and has been at the forefront of shaping our healthcare portfolio. She co-founded Healtho, a consumer health information company, and has mentored over 100+ digital health and biotech startups at UCSF’s Clinical Innovation Center.

• ​Ella Fung, Co-Founder & CEO, Rosalind Dx

  • ​Ella is a scientist-turned-entrepreneur with 7 years of industry experience in both drug discovery and diagnostics development. As the CEO of Rosalind Dx, she’s pioneering innovations in prenatal diagnostics, making life-saving tests more affordable and accessible to women across the region.

• ​Tiffany Khoo, Founder & CEO, WeAssist

  • ​A dual qualified solicitor, Tiffany is the founder and CEO of WeAssist, which is transforming the way healthcare information is accessed and shared. Her company bridges gaps between patients, providers, and data, redefining healthcare accessibility through technology and making vital health information more accessible to all.

​What You Can Expect

​🩺 Founder's journeys: A behind-the-scenes look at our healthcare founders' challenges and journeys as they discuss their experience navigating Iterative’s program.

​🙋 Interactive AMA Session: Bring your burning questions about healthcare innovation, what we're looking to fund, and the Iterative program itself.

​Who Should Attend?

​This session is tailored for healthcare founders in Southeast Asia. If you are looking to scale your startup, seek funding, or are interested in connecting with a community of healthcare founders, this AMA is for you. Iterative backs early stage founders of healthtech as well as biotech - read about our Request for Startups here. We are now accepting applications for our Winter 25 batch.

​About Iterative

​Iterative is a YC-style program focused exclusively on Southeast Asia. Iterative invests up to US500K in a batch of startups twice a year. The investment includes 3-months of targeted growth and fundraising support, which culminates in a Demo Day to a network of 400+ investors.

​Iterative is now accepting applications for our Winter 2025 batch program. No fees, an upfront investment of up to USD $500K upon admission, and 3 months of targeted support from experts and visiting partners. Learn more here.

​Since Iterative started in March 2020, we have raised $65M across two funds, invested in 100+ companies, 200+ founders and the total value of Iterative companies is now worth $1.2 billion.

​About Rosalind Dx

​Rosalind Dx is a venture-backed diagnostics startup. We are making prenatal testing more accessible and affordable with our proprietary technology, enhancing diagnostic accuracy and care for expectant mothers worldwide.

​About WeAssist

​WeAssist was established in 2020 with the belief of connecting people to healthcare services, in a way that is faster, easier and safer. Since our launch, we’ve facilitated over 600,000 hours of work through our platform, supporting healthcare professionals and facilities alike. Last year alone, we processed over USD 1.8 million in transactions. Our growth reflects the real difference we make in connecting healthcare facilities with professionals, creating a more responsive and adaptable healthcare system for everyone.